AAD Hair Loss Treatment: Minoxidil vs Finasteride Guide
Finasteride (Rx, $3-30/mo) blocks DHT; minoxidil 5% (OTC, $8-50/mo) boosts follicular blood flow. Compare FDA approval, cost, and access for androgenetic alopecia.
80 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 80 of 80 clinical reviews.
Finasteride (Rx, $3-30/mo) blocks DHT; minoxidil 5% (OTC, $8-50/mo) boosts follicular blood flow. Compare FDA approval, cost, and access for androgenetic alopecia.
A head-to-head comparison of isotretinoin and spironolactone for acne treatment, covering cost, insurance access, clinical efficacy, side effects, and prescribing requirements.
A clinical comparison of isotretinoin and spironolactone for acne treatment, covering efficacy data, side effects, patient selection, and when each drug is the better choice.
A clinical comparison of isotretinoin and spironolactone side effects for acne treatment, including teratogenicity, hormonal effects, lab monitoring, and long-term safety data.
Clinical comparison of isotretinoin and spironolactone for acne, including when and how to switch between these treatments safely.
A detailed comparison of dutasteride (Avodart) and isotretinoin (Accutane) covering pricing, insurance coverage, iPLEDGE requirements, generic availability, and clinical evidence for hair loss and severe acne.
Dutasteride (Avodart) and isotretinoin (Accutane) treat different dermatologic conditions. Compare their efficacy data, trial outcomes, mechanisms, and clinical roles side by side.
A clinical comparison of dutasteride (Avodart) and isotretinoin (Accutane) side-effect profiles, covering sexual health, teratogenicity, liver function, mental health, and more, prepared by the HealthRX.com Editorial Team.
A clinical comparison of dutasteride (Avodart) and isotretinoin (Accutane) covering mechanisms, indications, safety profiles, and how to switch between them safely.
A detailed comparison of dutasteride (Avodart) and spironolactone covering efficacy for hair loss and hormonal acne, cost, insurance coverage, off-label use, and how to choose between them.
A clinical comparison of dutasteride (Avodart) and spironolactone for skin and hair conditions, with evidence-based guidance on how and when to switch between the two medications.
A clinical comparison of dutasteride (Avodart) and topical minoxidil 5% covering cost, insurance access, efficacy data, and prescribing considerations for androgenetic alopecia.
Comparing dutasteride (Avodart) and topical minoxidil 5% for androgenetic alopecia. Mechanisms, trial data, side effects, and which works better for hair regrowth.
Clinical guide to switching between dutasteride (Avodart) and topical minoxidil 5% for hair loss, including transition protocols, timelines, and what to expect during the switch.
A clinical comparison of dutasteride (Avodart) and topical minoxidil 5% side effects, covering sexual adverse events, scalp irritation, systemic risks, and evidence from named trials.
Compare dutasteride (Avodart) and spironolactone for hormonal acne and androgenetic alopecia. Mechanisms, trial data, side effects, and which patients benefit most from each drug.
A clinical comparison of dutasteride and spironolactone side effects for acne and hair loss, including sexual dysfunction rates, hyperkalemia risk, and monitoring requirements.
Dutasteride cuts DHT ~90% vs 70% for finasteride and gave higher hair counts (109.6 vs 75.6/inch²) at 24 weeks, but only finasteride is FDA-approved for hair loss.
Finasteride causes sexual side effects in 1.3% to 3.8% of men; topical minoxidil causes scalp irritation in 3% to 7%. See how the risks compare.
A clinical comparison of finasteride and isotretinoin (Accutane), including when and how to switch between these medications safely for hair loss and severe acne.
A clinical comparison of finasteride for androgenetic alopecia and isotretinoin (Accutane) for severe acne, covering efficacy data, mechanisms, timelines, and side-effect profiles.
A clinical comparison of finasteride and isotretinoin side effects, covering sexual dysfunction, teratogenicity, liver impact, psychiatric risks, and monitoring requirements.
A clinical comparison of finasteride and dutasteride (Avodart) covering drug costs, insurance coverage, pharmacy access, efficacy data from named trials, and practical guidance for hair loss treatment selection.
A detailed head-to-head comparison of finasteride and dutasteride (Avodart) side-effect profiles, efficacy data, and clinical decision-making guidance for androgenetic alopecia and BPH.
Clinical guide to switching between finasteride and dutasteride (Avodart) for hair loss, including dosing protocols, washout timelines, and what the evidence says about efficacy differences.
A clinical comparison of finasteride and oral minoxidil for androgenetic alopecia, including how to switch between them safely, with trial data, dosing tables, and guidance.
A clinical comparison of finasteride and spironolactone covering mechanism, efficacy evidence, monthly cost, insurance coverage, and who qualifies for each drug.
A clinical comparison of finasteride and spironolactone for androgenic skin and hair conditions, covering mechanisms, dosing, side effects, and which drug fits which patient profile, with notes on where evidence is strong and where it is thin.
A detailed clinical comparison of finasteride and spironolactone side-effect profiles, covering sexual dysfunction, electrolyte risks, hormonal effects, and which drug suits which patient.
A clinical comparison of finasteride and spironolactone for androgenetic alopecia and hormonal acne, including when and how to switch between them safely.
A clinical comparison of finasteride 1 mg oral and topical minoxidil 5% for androgenetic alopecia, covering mechanism, trial data, side effects, and combination therapy.
Clinical comparison of finasteride and topical minoxidil for androgenetic alopecia, including when and how to switch between treatments safely.
A detailed comparison of finasteride and tretinoin covering pricing, insurance coverage, prescription access, generic availability, and clinical value for hair loss and skin health.
Finasteride and tretinoin treat entirely different dermatologic conditions. This evidence-based comparison breaks down their mechanisms, clinical trial outcomes, side-effect profiles, and when each drug is the right choice.
A clinical comparison of finasteride and tretinoin, including when and how to switch between these two drugs, what each treats, and key safety considerations.
Oral minoxidil causes hypertrichosis in 15-93% of users and edema in 2-5%, versus topical's 3-7% scalp irritation with minimal systemic absorption.
Finasteride risks sexual dysfunction in 2-4% of users; oral minoxidil mainly causes hypertrichosis and, at higher doses, fluid retention and tachycardia.
Topical minoxidil and tretinoin lack direct comparable side-effect data; oral minoxidil risks don't apply topically. See what to ask your clinician first.
No head-to-head trial exists, but finasteride blocks DHT while oral minoxidil extends the growth phase. Compare dosing, FDA status, and onset time.
Oral finasteride is FDA-approved for hair loss and usually covered by insurance; oral minoxidil is off-label and often denied, though both drugs are cheap generics.
A direct clinical and cost comparison of low-dose oral minoxidil for hair loss versus isotretinoin (Accutane) for acne. Learn which drug fits your condition, budget, and access pathway.
A clinical comparison of oral minoxidil for hair loss and isotretinoin (Accutane) for severe acne, covering efficacy data, trial outcomes, dosing, side effects, and which patients benefit from each drug.
A clinical comparison of oral minoxidil and isotretinoin (Accutane) side effects, covering cardiovascular risks, mucocutaneous drying, teratogenicity, lab monitoring, and long-term safety data.
A clinical comparison of low-dose oral minoxidil and isotretinoin (Accutane), including when to switch, how to switch safely, and what the evidence says about each drug's efficacy, dosing, and side-effect profile.
A clinical comparison of oral minoxidil and Avodart (dutasteride) for hair loss, covering pricing, insurance coverage, prescribing access, and efficacy data from key trials.
A detailed clinical comparison of oral minoxidil and dutasteride (Avodart) for androgenetic alopecia, covering mechanism, trial data, dosing, side effects, and when to combine both.
A clinical comparison of oral minoxidil and dutasteride (Avodart) side effects for hair loss, covering cardiovascular risks, sexual dysfunction, hypertrichosis, and monitoring needs.
A clinical comparison of low-dose oral minoxidil and dutasteride (Avodart) for androgenetic alopecia, including when and how to switch between them safely.
A clinical comparison of oral minoxidil and spironolactone covering pricing, insurance coverage, prescribing access, and evidence for hair loss and hormonal acne in 2026.
Spironolactone for hair loss: of 395 women with androgenetic alopecia, 74.3% improved or stabilized. Doses 100-200 mg daily; results take 6-12 months.
A clinical comparison of adverse-effect profiles for low-dose oral minoxidil and spironolactone, covering cardiovascular risks, hormonal effects, and monitoring requirements.
A clinical comparison of low-dose oral minoxidil and spironolactone for hair loss and acne, including when and how to switch between them, side effects, monitoring, and what the evidence says about each drug.
A direct clinical comparison of oral low-dose minoxidil versus topical 5% minoxidil for hair loss, covering efficacy data, side-effect profiles, real costs, and how to access each form through a telehealth provider.
Evidence-based comparison of low-dose oral minoxidil and topical minoxidil 5% for androgenetic alopecia, including what head-to-head trial evidence actually shows, side effect profiles, and how clinicians decide between routes.
A clinical comparison of oral low-dose minoxidil and topical minoxidil 5% for hair loss, including evidence on efficacy, side effects, and how to safely switch between formulations.
A head-to-head comparison of oral minoxidil and tretinoin covering cost, insurance access, prescribing pathways, clinical evidence, and which patients benefit most from each medication.
A clinical comparison of oral minoxidil and topical tretinoin covering mechanisms, trial outcomes, side effects, and which patients benefit most from each therapy.
A comparison of low-dose oral minoxidil and topical tretinoin covering indications, side-effect profiles, and a step-by-step protocol for switching between the two.
A clinical comparison of oral low-dose minoxidil and topical tretinoin side effects, covering cardiovascular risks, skin irritation, hypertrichosis, teratogenicity, and monitoring protocols.
A clinical comparison of topical minoxidil 5% and isotretinoin (Accutane) covering indications, cost, access barriers, safety, and how to choose between them.
Showing the first 60 matches. Use search or filters to narrow the library.